Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.
2.

The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues.

Fütterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K.

Immunity. 1998 Jul;9(1):59-70.

3.
4.
5.

Disruption of the Bcl6 gene results in an impaired germinal center formation.

Fukuda T, Yoshida T, Okada S, Hatano M, Miki T, Ishibashi K, Okabe S, Koseki H, Hirosawa S, Taniguchi M, Miyasaka N, Tokuhisa T.

J Exp Med. 1997 Aug 4;186(3):439-48.

6.

Inducible expression and phosphorylation of coactivator BOB.1/OBF.1 in T cells.

Zwilling S, Dieckmann A, Pfisterer P, Angel P, Wirth T.

Science. 1997 Jul 11;277(5323):221-5.

7.

The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation.

Ye BH, Cattoretti G, Shen Q, Zhang J, Hawe N, de Waard R, Leung C, Nouri-Shirazi M, Orazi A, Chaganti RS, Rothman P, Stall AM, Pandolfi PP, Dalla-Favera R.

Nat Genet. 1997 Jun;16(2):161-70.

PMID:
9171827
8.

Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation.

Greiner A, Knörr C, Qin Y, Sebald W, Schimpl A, Banchereau J, Müller-Hermelink HK.

Am J Pathol. 1997 May;150(5):1583-93.

9.

Control of inflammation, cytokine expression, and germinal center formation by BCL-6.

Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM.

Science. 1997 Apr 25;276(5312):589-92.

10.

B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1.

Nielsen PJ, Georgiev O, Lorenz B, Schaffner W.

Eur J Immunol. 1996 Dec;26(12):3214-8.

PMID:
8977324
11.
12.

The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes.

Kim U, Qin XF, Gong S, Stevens S, Luo Y, Nussenzweig M, Roeder RG.

Nature. 1996 Oct 10;383(6600):542-7.

PMID:
8849728
13.

B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation.

Schubart DB, Rolink A, Kosco-Vilbois MH, Botteri F, Matthias P.

Nature. 1996 Oct 10;383(6600):538-42.

PMID:
8849727
14.

Immunohistochemical analysis of proliferating and antigen-presenting cells in rheumatoid synovial tissue.

Krenn V, Schalhorn N, Greiner A, Molitoris R, König A, Gohlke F, Müller-Hermelink HK.

Rheumatol Int. 1996;15(6):239-47.

PMID:
8778952
15.

Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B.

Cepek KL, Chasman DI, Sharp PA.

Genes Dev. 1996 Aug 15;10(16):2079-88.

16.

Heterogeneity of breakpoints at the transcriptional co-activator gene, BOB-1, in lymphoproliferative disease.

Yuille MA, Galiegue-Zouitina S, Hiorns LR, Jadayel D, De Schouwer PJ, Catovsky D, Dyer MJ, Kerckaert JP.

Leukemia. 1996 Sep;10(9):1492-6.

PMID:
8751468
17.

BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor.

Chang CC, Ye BH, Chaganti RS, Dalla-Favera R.

Proc Natl Acad Sci U S A. 1996 Jul 9;93(14):6947-52.

18.

Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1.

Schubart DB, Sauter P, Massa S, Friedl EM, Schwarzenbach H, Matthias P.

Nucleic Acids Res. 1996 May 15;24(10):1913-20. Erratum in: Nucleic Acids Res 1996 Jun 15;24(12):2462.

19.
20.

BCL-6 expression during B-cell activation.

Allman D, Jain A, Dent A, Maile RR, Selvaggi T, Kehry MR, Staudt LM.

Blood. 1996 Jun 15;87(12):5257-68.

Supplemental Content

Support Center